Recursion Pharmaceuticals, Inc. (RXRX)

USD 6.22

(-12.71%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019
Total Assets 653.69 Million 701.28 Million 610.34 Million 298.58 Million 101.43 Million
Total Current Assets 438.13 Million 569.81 Million 534.71 Million 269.47 Million 76.39 Million
Cash And Short Term Investments 394.79 Million 549.91 Million 516.56 Million 262.12 Million 69.88 Million
Cash and Cash Equivalents 394.79 Million 549.91 Million 285.11 Million 262.12 Million 69.88 Million
Short Term Investments - - 231.44 Million - -
Net Receivables 3.09 Million 2.75 Million 9.09 Million 156 Thousand 151 Thousand
Inventory -3.09 Million 1.28 Million 1.55 Million 5.04 Million 5.28 Million
Other Current Assets 40.24 Million 15.86 Million 7.51 Million 2.15 Million 1.07 Million
Total Non-Current Assets 215.56 Million 131.47 Million 75.62 Million 29.1 Million 25.03 Million
Net PPE 120.17 Million 121.44 Million 64.72 Million 25.96 Million 24.37 Million
Good Will And Intangible Assets 88.49 Million 2.1 Million 2.18 Million 2.49 Million -
Good Will 52.05 Million 801 Thousand 801 Thousand 801 Thousand -
Intangible Assets 36.44 Million 1.3 Million 1.38 Million 2.49 Million -
Long-Term Investments 6.62 Million 7.92 Million 8.68 Million - -
Tax Assets -1.00 -7.92 Million -8.68 Million - -
Other Non Current Assets 261 Thousand 7.92 Million 8.71 Million 650 Thousand 663 Thousand
Other Assets 1.00 - - - -
Total Liabilities 190.26 Million 215.48 Million 67.4 Million 504.87 Million 225.69 Million
Total Current Liabilities 93.17 Million 100.26 Million 46.65 Million 23.09 Million 6.68 Million
Account Payables 3.95 Million 4.58 Million 2.81 Million 1.07 Million 1.26 Million
Tax Payables - - - 278 Thousand 292 Thousand
Short Term Debt 6.15 Million 6.04 Million 1.5 Million 1.54 Million 544 Thousand
Deferred Revenue 36.42 Million 56.72 Million 10 Million 10 Million -
Other Current Liabilities 46.63 Million 32.9 Million 32.33 Million 10.48 Million 4.87 Million
Total Non Current Liabilities 97.09 Million 115.21 Million 20.74 Million 481.77 Million 219.01 Million
Long-Term Debt 1.1 Million 44.95 Million 9.97 Million 14.12 Million 15.62 Million
Deferred Revenue Non Current 51.23 Million 70.26 Million 6.66 Million 16.66 Million 2.27 Million
Deferred Tax Liabilities Non Current - - - - -
Other Non Current Liabilities 43.41 Million -536 Thousand 4.11 Million 450.98 Million 203.38 Million
Other Liabilities - - - - -
Total Equity 463.43 Million 485.8 Million 542.93 Million -206.28 Million -124.26 Million
Stock Holders Equity 463.43 Million 485.8 Million 542.93 Million -206.28 Million -124.26 Million
Common Stock 2000.00 2000.00 2000.00 - -
Retained Earnings -967.62 Million -639.55 Million -400.08 Million -213.6 Million -126.59 Million
Accumulated other comprehensive income - - -126 Thousand - -
Common Stock Equity 463.43 Million 485.8 Million 542.93 Million -206.28 Million -124.26 Million
Capital Lease Obligation 43.41 Million 50.37 Million 10.75 Million 3.17 Million 3.67 Million
Total Investments 6.62 Million 7.92 Million 231.44 Million - -
Total Debt 50.67 Million 51 Million 11.47 Million 15.66 Million 16.16 Million
Net Debt -344.12 Million -498.9 Million -273.63 Million -246.46 Million -53.71 Million

Balance Sheet Charts